Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Top SEHK Dividend Stocks Including PC Partner Group

In This Article:

As global markets navigate a period of economic adjustment, the Hong Kong market has experienced fluctuations, with the Hang Seng Index recently facing a decline. Amidst these dynamics, dividend stocks remain a focal point for investors seeking steady income streams in uncertain times. In this article, we explore three notable dividend stocks on the Stock Exchange of Hong Kong (SEHK), including PC Partner Group, that exemplify resilience and potential for consistent returns in today's market environment.

Top 10 Dividend Stocks In Hong Kong

Name

Dividend Yield

Dividend Rating

Luk Fook Holdings (International) (SEHK:590)

9.09%

★★★★★☆

China Hongqiao Group (SEHK:1378)

8.53%

★★★★★☆

Chongqing Rural Commercial Bank (SEHK:3618)

7.15%

★★★★★☆

Bank of China (SEHK:3988)

7.01%

★★★★★☆

Playmates Toys (SEHK:869)

8.70%

★★★★★☆

Lion Rock Group (SEHK:1127)

7.97%

★★★★★☆

China Construction Bank (SEHK:939)

7.10%

★★★★★☆

PC Partner Group (SEHK:1263)

8.37%

★★★★★☆

Tianjin Development Holdings (SEHK:882)

6.92%

★★★★★☆

Sinopharm Group (SEHK:1099)

4.66%

★★★★★☆

Click here to see the full list of 91 stocks from our Top SEHK Dividend Stocks screener.

Let's uncover some gems from our specialized screener.

PC Partner Group

Simply Wall St Dividend Rating: ★★★★★☆

Overview: PC Partner Group Limited is an investment holding company that designs, develops, manufactures, and sells computer electronics with a market cap of HK$1.85 billion.

Operations: The company's revenue primarily comes from the design, manufacturing, and trading of electronics and PC parts and accessories, amounting to HK$9.94 billion.

Dividend Yield: 8.4%

PC Partner Group has shown a positive trend in dividend payments over the past decade, despite some volatility. The company's dividends are well-covered by both earnings and cash flows, with a payout ratio of 66.1% and a cash payout ratio of 7.8%. Recent financial results indicate improved profitability, with net income rising to HK$194.06 million for the first half of 2024. However, its removal from the S&P Global BMI Index may impact investor perception.

SEHK:1263 Dividend History as at Oct 2024
SEHK:1263 Dividend History as at Oct 2024

Consun Pharmaceutical Group

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Consun Pharmaceutical Group Limited is engaged in the research, development, manufacturing, and sale of Chinese medicines and medical contrast medium products in the People’s Republic of China, with a market cap of HK$6.62 billion.

Operations: Consun Pharmaceutical Group's revenue is primarily derived from the Consun Pharmaceutical Segment, which accounts for CN¥2.33 billion, and the Yulin Pharmaceutical Segment, contributing CN¥410 million.